TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells

Lipids in Health and Disease

Research

Jiang Wei¹  Guanghua Luo¹  Yuanping Shi¹  Zongchun Wang²  Chunhua Zhu²  Dongmei Di²  Xiaoying Zhang²  Maria Berggren-Söderlund³  Peter Nilsson-Ehle³  Ning Xu³ 

[1] Comprehensive Laboratory, Third Affiliated Hospital of Suzhou University, 213003, Changzhou, P.R., China;Department of Cardiothoracic Surgery, Third Affiliated Hospital of Suzhou University, 213003, Changzhou, P.R., China;Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lunds University, S-221 85, Lund, Sweden;

关键词: Liver X Receptor;    Farnesoid X Receptor;    Caco-2 cell line;    Apolipoprotein M;   

DOI  :  10.1186/1476-511X-10-199

 received in 2011-09-22, accepted in 2011-11-04,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundApolipoprotein M (apoM) may have potential antiatherosclerotic properties. It has been reported that apoM expression could be regulated by many intracellar and extracellar factors. In the present study we further investigated regulation of apoM expression in Caco-2 cells stimulated by a liver X receptor (LXR) agonist, TO901317.Materials and methodsCaco-2 cells were cultured in the presence of either TO901317, farnesoid X receptor (FXR) antagonist guggulsterone or TO901317 together with guggulsterone at different concentrations for 24 hrs. The mRNA levels of ATP-binding cassette transporter A1 (ABCA1), apoA1, apoM, liver receptor homologue-1 (LRH-1) and short heterodimer partner 1 (SHP1) were determined by real-time RT-PCR.ResultsWhen Caco-2 cell cultured with TO901317 alone, the mRNA levels of ABCA1, apoA1, apoM, LRH-1 and SHP1 were significantly increased with dose-dependent manners (p < 0.05), whereas when the cells cultured with guggulsterone alone, the mRNA levels of apoM, SHP1 and LRH-1 (p < 0.05) were strongly inhibited. Moreover, guggulsterone could abolish the TO901317 enhanced mRNA levels of apoA1 apoM, SHP1 and LRH-1.ConclusionThe present study demonstrated that LXR agonist TO901317 induced apoM expression in Caco-2 cells might be mediated via the LXR/FXR pathway.

【 授权许可】

Unknown   
© Zhu et al; licensee BioMed Central Ltd. 2011. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.